@article {Mankoff525, author = {David A. Mankoff and Daniel A. Pryma and Amy S. Clark}, title = {Molecular Imaging Biomarkers for Oncology Clinical Trials}, volume = {55}, number = {4}, pages = {525--528}, year = {2014}, doi = {10.2967/jnumed.113.126128}, publisher = {Society of Nuclear Medicine}, abstract = {Biomarkers can be used to characterize disease status or predict disease behavior. Cancer biomarkers have typically relied on assays of blood or tissue; however, molecular imaging has a promising and complementary role as a cancer biomarker. This {\textquotedblleft}Focus on Molecular Imaging{\textquotedblright} article reviews the current role of biomarkers to direct cancer clinical trials and clinical practice, along with current and future cancer biomarker applications of molecular imaging.}, issn = {0161-5505}, URL = {https://jnm.snmjournals.org/content/55/4/525}, eprint = {https://jnm.snmjournals.org/content/55/4/525.full.pdf}, journal = {Journal of Nuclear Medicine} }